Pacira BioSciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 177.4M | 196.9M | 179.5M | 181.1M | 168.9M | 187.3M | 168.6M | 178.0M |
| Cost of Goods Sold | 36.4M | 40.3M | 34.3M | 40.9M | 34.3M | 39.9M | 38.9M | 44.3M |
| Gross Profit | 141.0M | 156.6M | 145.2M | 140.2M | 134.6M | 147.4M | 129.7M | 133.8M |
| R&D Expenses | 28.1M | 37.5M | 26.0M | 28.2M | 25.3M | 23.9M | 19.1M | 20.3M |
| Operating Expenses | 136.3M | 153.4M | 138.9M | 131.7M | 132.6M | 122.7M | 269.2M | 105.5M |
| Operating Income | 4.6M | 3.2M | 6.4M | 8.5M | 2.0M | 24.7M | -139.5M | 28.2M |
| Other Income / Gains | 373K | -2.6M | 3.2M | -10.4M | 6.7M | 822K | 671K | 8.3M |
| Net Income | 2.9M | 1.6M | 5.4M | -4.8M | 4.8M | 16.0M | -143.5M | 18.9M |
| EPS (Diluted) | 0.072 | 0.04 | 0.12 | -0.11 | 0.10 | 0.35 | -3.11 | 0.41 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.795 | 0.795 | 0.809 | 0.774 | 0.797 | 0.787 | 0.769 | 0.751 |
| General And Administrative Expenses | 35.8M | 40.0M | 33.3M | 37.6M | 31.2M | 29.3M | 31.1M | 29.1M |
| Selling And Marketing Expenses | 58.2M | 61.6M | 58.5M | 51.0M | 55.6M | 50.3M | 43.2M | 39.0M |
| Selling General And Administrative Expenses | 93.9M | 101.6M | 91.8M | 88.6M | 86.8M | 79.6M | 74.3M | 68.1M |
| Other Expenses | 14.3M | 14.3M | 21.1M | 15.0M | 20.5M | 19.2M | 175.8M | 17.1M |
| Cost And Expenses | 172.8M | 193.7M | 173.2M | 172.6M | 166.9M | 162.5M | 308.1M | 149.8M |
| Interest Income | 1.9M | 2.3M | 8.5M | 5.0M | 6.9M | 5.6M | 5.5M | 4.7M |
| Interest Expense | 3.2M | 3.4M | 3.7M | 4.7M | 4.6M | 3.8M | 4.7M | 3.1M |
| Depreciation And Amortization | 21.3M | 21.3M | 21.2M | 27.3M | 21.2M | 21.2M | 20.3M | 18.9M |
| Ebitda | 29.5M | 25.3M | 34.4M | 29.2M | 33.6M | 50.6M | -114.8M | 58.6M |
| Ebitdaratio | 0.166 | 0.128 | 0.191 | 0.161 | 0.199 | 0.27 | -0.681 | 0.329 |
| Operating Income Ratio | 0.026 | 0.016 | 0.035 | 0.047 | 0.012 | 0.132 | -0.828 | 0.159 |
| Income Before Tax | 5.0M | 571K | 9.5M | -1.9M | 8.7M | 25.5M | -138.9M | 36.6M |
| Income Before Tax Ratio | 0.028 | 0.003 | 0.053 | -0.011 | 0.052 | 0.136 | -0.824 | 0.206 |
| Income Tax Expense | 2.1M | -1.1M | 4.1M | 2.9M | 3.9M | 9.5M | 4.6M | 17.7M |
| Net Income Ratio | 0.016 | 0.008 | 0.03 | -0.027 | 0.028 | 0.086 | -0.851 | 0.106 |
| Epsdiluted | 0.071 | 0.04 | 0.12 | -0.11 | 0.10 | 0.34 | -3.11 | 0.39 |
| Weighted Average Shs Out | 40.5M | 42.5M | 44.0M | 45.5M | 46.3M | 46.2M | 46.1M | 46.2M |
| Weighted Average Shs Out Dil | 40.9M | 43.0M | 44.5M | 45.5M | 46.5M | 49.0M | 46.1M | 50.5M |